Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression

Biochemical and Biophysical Research Communications

Volumn 426, Issue 2, 2012, Pages 177-182

  Kim, Felix J ^a   Schrock, Joel M ^b   Spino, Christina M ^a   Marino, Jacqueline C ^b   Pasternak, Gavril W ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell mass; Protein translation; Sigma1 ligand; Sigma1 receptor; Tumor

Indexed keywords

(1(4 IODOPHENYL) 3(2 ADAMANTYL) GUANIDINE); CYTOTOXIC AGENT; HALOPERIDOL; INITIATION FACTOR 4E BINDING PROTEIN 1; LIGAND; MEMBRANE PROTEIN; MEMBRANE PROTEIN SIGMA1; PREO 84; PROTEIN S6; S6 KINASE; SKF 100047; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL SIZE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TRANSLATION INITIATION; TRANSLATION REGULATION; TUMOR GROWTH;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; HALOPERIDOL; HUMANS; LIGANDS; MORPHOLINES; NEOPLASMS; PHENAZOCINE; PROTEIN BIOSYNTHESIS; RECEPTORS, SIGMA; RNA CAP-BINDING PROTEINS;

EID: 84866402267     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.052     Document Type: Article

References (27)

1. Hanner M., Moebius F.F., Flandorfer A., et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl. Acad. Sci. USA 1996, 93:8072-8077.
2. Kekuda R., Prasad P.D., Fei Y.J., et al. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 1996, 229:553-558.
3. Seth P., Fei Y.J., Li H.W., et al. Cloning and functional characterization of a sigma receptor from rat brain. J. Neurochem. 1998, 70:922-931.
4. Seth P., Leibach F.H., Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem. Biophys. Res. Commun. 1997, 241:535-540.
5. Aydar E., Palmer C.P., Klyachko V.A., et al. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 2002, 34:399-410.
6. Jbilo O., Vidal H., Paul R., et al. Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J. Biol. Chem. 1997, 272:27107-27115.
7. Hayashi T., Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007, 131:596-610.
8. Martin W.R., Eades C.G., Thompson J.A., et al. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976, 197:517-532.
9. Quirion R., Bowen W.D., Itzhak Y., et al. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13:85-86.
10. Su T.P., Hayashi T., Maurice T., et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 2010, 31:557-566.
11. Vilner B.J., John C.S., Bowen W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995, 55:408-413.
12. Aydar E., Palmer C.P., Djamgoz M.B. Sigma receptors and cancer: possible involvement of ion channels. Cancer Res. 2004, 64:5029-5035.
13. Spruce B.A., Campbell L.A., McTavish N., et al. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res. 2004, 64:4875-4886.
14. Brent P.J., Pang G., Little G., et al. The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. Biochem. Biophys. Res. Commun. 1996, 219:219-226.
15. Crawford K.W., Bowen W.D. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res. 2002, 62:313-322.
16. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 2009, 10:307-318.
17. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
18. Jones R.G., Thompson C.B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009, 23:537-548.
19. Ruggero D., Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev. Cancer 2003, 3:179-192.
20. Richter J.D., Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005, 433:477-480.
21. Fingar D.C., Salama S., Tsou C., et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002, 16:1472-1487.
22. Hosokawa N., Hara Y., Mizushima N. Generation of cell lines with tetracycline-regulated autophagy and a role for autophagy in controlling cell size. FEBS Lett. 2006, 580:2623-2629.
23. She Q.B., Halilovic E., Ye Q., et al. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 2010, 18:39-51.
24. Carver B.S., Chapinski C., Wongvipat J., et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 2011, 19:575-586.
25. Zhang S., Yu D. PI(3)king apart PTEN's role in cancer. Clin. Cancer Res. 2010, 16:4325-4330.
26. Ostenfeld M.S., Fehrenbacher N., Hoyer-Hansen M., et al. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res. 2005, 65:8975-8983.
27. Piergentili A., Amantini C., Del Bello F., et al. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane. J. Med. Chem. 2010, 53:1261-1269.